B
REGN icon

Baird’s Regeneron Pharmaceuticals REGN Stock Holding History

Baird’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$6.23M Sell
13,790
-5,331
-28% -$2.26M 0.06% 297
2014
Q4 		$7.84M Sell
19,121
-143
-0.7% -$56.2K 0.08% 252
2014
Q3 		$6.95M Buy
19,264
+57
+0.3% +$19.1K 0.1% 201
2014
Q2 		$5.42M Buy
19,207
+1,061
+6% +$314K 0.08% 239
2014
Q1 		$5.45M Buy
18,146
+11,255
+163% +$3.47M 0.08% 250
2013
Q4 		$1.9M Buy
6,891
+278
+4% +$80K 0.03% 471
2013
Q3 		$2.07M Buy
6,613
+2,810
+74% +$739K 0.04% 434
2013
Q2 		$855K Buy
+3,803
New +$886K 0.02% 612

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return